ctDNA has been shown to be effective as a treatment decision tool for adjuvant chemotherapy in colon cancer
Controlled approaches using circulating tumor DNA can reduce the number of patients receiving adjuvant chemotherapy without the risk of reducing recurrence-free survival in some patients with stage II colon cancer. Controlled approaches using circulating tumor DNA (ctDNA) may, according to the DYNAMIC Phase 2 study, reduce the number of patients receiving adjuvant chemotherapy without the …